The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,599.00
Bid: 4,598.00
Ask: 4,599.00
Change: 2.00 (0.04%)
Spread: 1.00 (0.022%)
Open: 4,585.00
High: 4,615.00
Low: 4,577.00
Prev. Close: 4,597.00
RKT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

6 Mar 2024 07:00

RNS Number : 7131F
Reckitt Benckiser Group PLC
06 March 2024
 

Transaction in own shares

 

Reckitt Benckiser Group plc (the "Company") announces today it has purchased the following number of its ordinary shares of 10 pence each ("shares") from Merrill Lynch International in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2023 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 19 December 2023, as announced on 20 December 2023. The repurchased shares will be held in treasury.

 

Ordinary Shares

 

Date of purchase:

5 March 2024

Aggregate number of ordinary shares purchased:

207,856

Highest price paid per share (pence):

5,142.00

Lowest price paid per share (pence):

5,088.00

Volume weighted average price paid per share (pence):

5,114.11

 

Following settlement of the above transaction, the Company will hold 25,711,286 of its ordinary shares in treasury and have 710,823,893 ordinary shares in issue (excluding treasury shares).

 

Therefore, the total number of voting rights in the Company will be 710,823,893 and this figure may be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it applies in the UK, a full breakdown of the individual trades made by the Broker on behalf of the Company is detailed below: 

 

http://www.rns-pdf.londonstockexchange.com/rns/7131F_1-2024-3-5.pdf

 

 

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSVELFBZXLBBBV
Date   Source Headline
1st Nov 202311:57 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTransaction in Own Shares
31st Oct 20237:00 amRNSTransaction in Own Shares
30th Oct 20237:00 amRNSShare Buyback Programme - First Tranche
27th Oct 20237:00 amRNSDirector/PDMR Shareholding
25th Oct 20237:00 amRNSStrategy Update
25th Oct 20237:00 amRNSQ3 Trading Statement
2nd Oct 202310:12 amRNSTotal Voting Rights
18th Sep 20234:30 pmRNSDirector/PDMR Shareholding
14th Sep 20232:30 pmRNSEMTN Programme: Publication of Final Terms
5th Sep 20239:35 amRNSPublication of Base Prospectus
1st Sep 202311:16 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSCEO Transition
23rd Aug 20237:00 amRNSDirectorate Change
9th Aug 20233:15 pmRNSDirector/PDMR Shareholding
7th Aug 20234:31 pmRNSDirector/PDMR Shareholding
1st Aug 20239:50 amRNSTotal Voting Rights
27th Jul 20232:06 pmRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSHalf-year Report
3rd Jul 202310:58 amRNSTotal Voting Rights
1st Jun 202311:05 amRNSTotal Voting Rights
31st May 202312:15 pmRNSDirector/PDMR Shareholding
25th May 20235:00 pmRNSDirector/PDMR Shareholding
25th May 202312:00 pmRNSSmaller related party transaction
3rd May 20235:22 pmRNSResult of AGM
2nd May 20231:19 pmRNSTotal Voting Rights
26th Apr 20237:00 amRNSNew CEO Announcement
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 202311:20 amRNSTotal Voting Rights
22nd Mar 202311:30 amRNSDirector/PDMR Shareholding
22nd Mar 202310:05 amRNSAnnual Financial Report and Notice of AGM
1st Mar 20235:31 pmRNSCorrection: Last date for DRIP election
1st Mar 20237:01 amRNSTotal Voting Rights
1st Mar 20237:00 amRNSFinal Results
15th Feb 202311:00 amRNSDirector Declaration
1st Feb 202312:51 pmRNSTotal Voting Rights
3rd Jan 202311:19 amRNSTotal Voting Rights
13th Dec 202210:30 amRNSDirectorate Change
1st Dec 202212:00 pmRNSTotal Voting Rights
7th Nov 20222:57 pmRNSDirectorate Change
1st Nov 20222:55 pmRNSTotal Voting Rights
26th Oct 20227:00 amRNS3rd Quarter Results
20th Oct 20224:46 pmRNSHolding(s) in Company
3rd Oct 20222:43 pmRNSTotal Voting Rights
29th Sep 20224:59 pmRNSDirector/PDMR Shareholding
16th Sep 20222:54 pmRNSDirector/PDMR Shareholding
7th Sep 202212:00 pmRNSDirector/PDMR Shareholding
1st Sep 202210:55 amRNSTotal Voting Rights
1st Sep 20227:00 amRNSDirectorate Change
11th Aug 202210:27 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.